BUDESONID MEPHA caps ret 3 mg 100 pce bte

7680684700033 CH-68470 A07EA06 04.99.0.

Active substances:

No images available

Details

Product number
6847001
CPT
-
Packaging group
100
Unit
Kapsel(n)
Composition
budesonidum 3 mg, sacchari sphaerae corresp. saccharum 187.5 - 276 mg et maydis amylum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ammonio methacrylatis copolymerum B, ammonio methacrylatis copolymerum A, triethylis citras, talcum, Kapselhülle: E 133, E 104, E 127, E 171, gelatina, natrii laurilsulfas corresp. natrium 0.005 mg, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, glyceroli monocaprylocapras, poly(alcohol vinylicus), pro capsula.

Articles (1)

Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung 3mg
Kapseln
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2026
Patient information leaflet
Français
01/05/2026
Patient information leaflet
Italien
01/05/2026
Professional SmPC
Allemand
01/05/2026
Professional SmPC
Français
01/05/2026
Professional SmPC
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
budesonidum
3.0 MG Substance Wirkstoff (Principe actif)
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HBESI
maydis amylum
- Substance HNIDK
acidi methacrylici et methylis methacrylatis polymerisatum 1:1
- Substance HNIDK
acidi methacrylici et methylis methacrylatis polymerisatum 1:2
- Substance HNIDK
ammonio methacrylatis copolymerum B
- Substance HNIDK
ammonio methacrylatis copolymerum A
- Substance HNIDK
triethylis citras
- Substance HNIDK
talcum
- Substance HNIDK
E 133
- Substance FIMDK
E 104
- Substance FIMDK
E 127
- Substance FIMDK
E 171
- Substance FNIDK
gelatina
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
natrium
0.005 MG Substance HBESI
copolymerum macrogolo et alcoholi poly(vinylico) constatum
- Substance HNIDK
talcum
- Substance HNIDK
glyceroli monocaprylocapras
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK

Reimbursement information

Public price
CHF 96.55
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2026

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
68470
Drug name
Budesonid-Mepha, Hartkapsel mit veränderter Wirkstofffreisetzung
Galenic form
KAHAM
ATC Code
A07EA06
Authorization status
Z
Dispensation category
B
First authorization
08/07/2022
Authorization expiration date
07/07/2027
IT number
04.99.0.
Domain
Human medicine
Field of application
Morbus Crohn, Kollagene Colitis

Packaging details

Description (FR)
BUDESONID MEPHA caps ret 3 mg 100 pce bte
Description (DE)
BUDESONID MEPHA Ret Kaps 3 mg 100 Stk Ds
Market launch
15/05/2026
Narcotic (BTM)
No

Original drug

Budenofalk 2 mg, Rektalschaum
CHF 102.55
View original

Other packaging sizes

BUDESONID MEPHA caps ret 3 mg 50 pce
50 KAP
View
BUDESONID MEPHA caps ret 3 mg 100 pce
100 KAP
View
Buy us a coffee Explore the data